Viral infections have long been thought of as an attractive therapeutic area for RNAi Therapeutics.  Unfortunately, with the exception of...

The use of the intravenous route of administration for the currently leading systemic RNAi delivery technology, Tekmira’s SNALP technol...

SNALP delivery technology has not only been the subject of a heated fight over ownership and control, but also continued mechanistic, c...

Arrowhead Research just announced the publication of a scientific paper detailing its fundamentally new DPC delivery approach (discusse...

[ please note the changes below after I discovered that I missed the last claim amendments, as correctly pointed out by a commenter ] ...

Transthyretin-mediated amyloidosis has become the single-most important factor for the 3-5 year valuation of certainly Alnylam, and pos...

A somewhat vexing problem with DNA-directed RNAi (ddRNAi) has been the heterogeneous mixture of small RNAs generated from a typical expre...